Creative Planning’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.39M Buy
113,100
+45,259
+67% +$2.64M ﹤0.01% 1006
2025
Q4
$4.03M Buy
67,841
+33,476
+97% +$1.82M ﹤0.01% 1163
2025
Q3
$1.86M Buy
34,365
+11,405
+50% +$652K ﹤0.01% 1610
2025
Q2
$1.26M Sell
22,960
-3,010
-12% -$177K ﹤0.01% 1665
2025
Q1
$1.84M Sell
25,970
-7,791
-23% -$524K ﹤0.01% 1231
2024
Q4
$2.22M Buy
33,761
+19,461
+136% +$1.3M ﹤0.01% 1068
2024
Q3
$1.01M Buy
14,300
+2,475
+21% +$207K ﹤0.01% 1506
2024
Q2
$974K Buy
11,825
+524
+5% +$43.6K ﹤0.01% 1416
2024
Q1
$987K Sell
11,301
-1
-0% -$90 ﹤0.01% 1349
2023
Q4
$1.09M Buy
11,302
+2,736
+32% +$242K ﹤0.01% 1183
2023
Q3
$758K Buy
8,566
+507
+6% +$45.1K ﹤0.01% 1298
2023
Q2
$699K Buy
8,059
+1,074
+15% +$101K ﹤0.01% 1339
2023
Q1
$679K Buy
6,985
+163
+2% +$16.9K ﹤0.01% 1297
2022
Q4
$706K Buy
6,822
+532
+8% +$49.9K ﹤0.01% 1225
2022
Q3
$533K Buy
6,290
+53
+0.8% +$4.72K ﹤0.01% 1295
2022
Q2
$517K Buy
6,237
+2,744
+79% +$218K ﹤0.01% 1297
2022
Q1
$269K Sell
3,493
-1,302
-27% -$109K ﹤0.01% 1702
2021
Q4
$424K Buy
4,795
+21
+0.4% +$1.73K ﹤0.01% 1402
2021
Q3
$369K Buy
4,774
+251
+6% +$19.8K ﹤0.01% 1471
2021
Q2
$377K Sell
4,523
-438
-9% -$34.7K ﹤0.01% 1435
2021
Q1
$375K Sell
4,961
-597
-11% -$48.8K ﹤0.01% 1637
2020
Q4
$487K Sell
5,558
-579
-9% -$45.9K ﹤0.01% 1333
2020
Q3
$467K Buy
6,137
+1,020
+20% +$103K ﹤0.01% 1171
2020
Q2
$631K Sell
5,117
-813
-14% -$80.8K ﹤0.01% 925
2020
Q1
$501K Sell
5,930
-3,774
-39% -$325K ﹤0.01% 943
2019
Q4
$820K Sell
9,704
-92
-0.9% -$6.95K ﹤0.01% 878
2019
Q3
$660K Buy
9,796
+132
+1% +$10.2K ﹤0.01% 930
2019
Q2
$828K Sell
9,664
-5,230
-35% -$447K ﹤0.01% 840
2019
Q1
$1.32M Sell
14,894
-3,142
-17% -$291K ﹤0.01% 623
2018
Q4
$1.54M Buy
18,036
+13,398
+289% +$1.27M 0.01% 496
2018
Q3
$450K Sell
4,638
-507
-10% -$50.6K ﹤0.01% 1137
2018
Q2
$485K Sell
5,145
-131
-2% -$11.5K ﹤0.01% 1086
2018
Q1
$428K Sell
5,276
-916
-15% -$78.6K ﹤0.01% 1157
2017
Q4
$552K Buy
6,192
+2,129
+52% +$185K ﹤0.01% 1019
2017
Q3
$378K Buy
4,063
+815
+25% +$72K ﹤0.01% 1189
2017
Q2
$295K Sell
3,248
-10,192
-76% -$927K ﹤0.01% 1297
2017
Q1
$1.18M Buy
13,440
+100
+0.7% +$8.9K 0.01% 608
2016
Q4
$1.1M Sell
13,340
-446
-3% -$38.4K 0.01% 590
2016
Q3
$1.27M Buy
13,786
+10,211
+286% +$962K 0.01% 510
2016
Q2
$278K Buy
3,575
+825
+30% +$70.1K ﹤0.01% 1091
2016
Q1
$227K Buy
2,750
+20
+0.7% +$1.63K ﹤0.01% 1146
2015
Q4
$286K Buy
2,730
+335
+14% +$35K ﹤0.01% 1012
2015
Q3
$252K Buy
+2,395
New +$320K ﹤0.01% 1059
2015
Q2
Sell
-1,770
Closed -$221K 1324
2015
Q1
$221K Sell
1,770
-9,409
-84% -$997K ﹤0.01% 1135
2014
Q4
$1.01M Buy
11,179
+7,437
+199% +$618K 0.01% 446
2014
Q3
$270K Sell
3,742
-3,778
-50% -$248K ﹤0.01% 917
2014
Q2
$468K Buy
7,520
+3,979
+112% +$240K 0.01% 670
2014
Q1
$242K Buy
3,541
+1,871
+112% +$138K ﹤0.01% 909
2013
Q4
$117K Sell
1,670
-130
-7% -$8.83K ﹤0.01% 1115
2013
Q3
$130K Sell
1,800
-11,434
-86% -$760K ﹤0.01% 964
2013
Q2
$738K Buy
+13,234
New +$825K 0.02% 301

Other funds holding BMRN